Link Securities | At the Extraordinary General Shareholders’ Meeting of Faes Farma (FAE) held on Wednesday, the proposal of the Board of Directors contained in the sole item on the Agenda was approved:
Approval of the acquisition of 100% of the share capital of Sifi, S.P.A.
With this approval by the shareholders, Faes Farma takes another step towards completing the acquisition of Sifi, which represents a transformational step in its strategy for 2030, strengthening its position in ophthalmology, a therapeutic area with significant growth potential, and accelerating its international expansion.
